Align Technology, Inc. (NASDAQ:ALGN) Shares Bought by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 8.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 2,110 shares of the medical equipment provider’s stock after acquiring an additional 167 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Align Technology were worth $578,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of ALGN. Huntington National Bank grew its stake in shares of Align Technology by 94.9% in the third quarter. Huntington National Bank now owns 115 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 56 shares in the last quarter. Compagnie Lombard Odier SCmA acquired a new stake in Align Technology in the third quarter valued at approximately $61,000. Orion Capital Management LLC purchased a new stake in shares of Align Technology during the third quarter valued at approximately $61,000. Operose Advisors LLC purchased a new position in shares of Align Technology in the third quarter valued at $63,000. Finally, Covestor Ltd boosted its stake in shares of Align Technology by 379.5% in the third quarter. Covestor Ltd now owns 211 shares of the medical equipment provider’s stock valued at $64,000 after purchasing an additional 167 shares during the period. Institutional investors and hedge funds own 88.43% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the company. Leerink Partnrs reaffirmed a “market perform” rating on shares of Align Technology in a research report on Monday, February 26th. Morgan Stanley raised their price target on shares of Align Technology from $344.00 to $360.00 and gave the stock an “overweight” rating in a research report on Thursday. UBS Group boosted their target price on shares of Align Technology from $280.00 to $320.00 and gave the stock a “neutral” rating in a research report on Monday, April 15th. SVB Leerink assumed coverage on Align Technology in a report on Monday, February 26th. They set a “market perform” rating and a $310.00 target price on the stock. Finally, Stifel Nicolaus boosted their price target on Align Technology from $350.00 to $400.00 and gave the company a “buy” rating in a report on Thursday, April 18th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Align Technology has a consensus rating of “Moderate Buy” and an average price target of $341.36.

Align Technology Trading Down 0.5 %

Shares of NASDAQ:ALGN opened at $309.02 on Friday. Align Technology, Inc. has a 52 week low of $176.34 and a 52 week high of $413.20. The firm has a market capitalization of $23.25 billion, a P/E ratio of 50.91, a PEG ratio of 5.56 and a beta of 1.65. The firm’s 50 day moving average is $313.38 and its two-hundred day moving average is $270.98.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, January 31st. The medical equipment provider reported $1.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.78 by $0.13. Align Technology had a return on equity of 14.15% and a net margin of 11.80%. The company had revenue of $956.73 million during the quarter, compared to analysts’ expectations of $928.57 million. Analysts predict that Align Technology, Inc. will post 7.69 EPS for the current year.

Insider Buying and Selling at Align Technology

In related news, EVP Emory Wright sold 2,524 shares of the stock in a transaction that occurred on Wednesday, February 7th. The shares were sold at an average price of $287.45, for a total transaction of $725,523.80. Following the completion of the sale, the executive vice president now directly owns 709 shares of the company’s stock, valued at $203,802.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, Director Joseph Lacob sold 15,000 shares of the firm’s stock in a transaction that occurred on Thursday, February 29th. The shares were sold at an average price of $303.22, for a total transaction of $4,548,300.00. Following the completion of the sale, the director now directly owns 131,994 shares in the company, valued at $40,023,220.68. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Emory Wright sold 2,524 shares of the company’s stock in a transaction on Wednesday, February 7th. The stock was sold at an average price of $287.45, for a total transaction of $725,523.80. Following the completion of the transaction, the executive vice president now directly owns 709 shares in the company, valued at $203,802.05. The disclosure for this sale can be found here. In the last three months, insiders sold 27,524 shares of company stock valued at $8,403,924. 0.64% of the stock is owned by insiders.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.